Adding happiness to complement the Dermatology Quality of Life Index in psoriasis and atopic dermatitis healthcare: a cross-sectional study

Adding happiness to complement the Dermatology Quality of Life Index in psoriasis and atopic dermatitis healthcare: a cross-sectional study.

Journal

European journal of dermatology : EJD
ISSN: 1952-4013
Titre abrégé: Eur J Dermatol
Pays: France
ID NLM: 9206420

Informations de publication

Date de publication:
01 04 2022
Historique:
entrez: 22 7 2022
pubmed: 23 7 2022
medline: 27 7 2022
Statut: ppublish

Résumé

The Dermatology Quality of Life Index (DLQI) is the most commonly used quality of life questionnaire in dermatology. The aim of this study was to compare the DLQI to measures of wellbeing and general quality of life in patients with chronic inflammatory skin diseases. A cross-sectional study among patients with psoriasis and atopic dermatitis was conducted at a hospital in Munich, Germany (12/2017-04/2019). Participants filled in validated scales measuring happiness, quality of life, and DLQI. In 102 patients with chronic inflammatory skin diseases, the DLQI was associated only with physical quality of life and negative emotions, and not psychological quality of life or positive affect. The DLQI alone accounted for 26% of variance in general quality of life. Combining DLQI and happiness accounted for a total of 73% of variance, with both variables contributing to the model. The DLQI alone only partially reflected well-being. Assessing happiness in addition to the widely used DLQI can contribute to a more comprehensive evaluation of well-being.

Sections du résumé

Background
The Dermatology Quality of Life Index (DLQI) is the most commonly used quality of life questionnaire in dermatology.
Objectives
The aim of this study was to compare the DLQI to measures of wellbeing and general quality of life in patients with chronic inflammatory skin diseases.
Materials & Methods
A cross-sectional study among patients with psoriasis and atopic dermatitis was conducted at a hospital in Munich, Germany (12/2017-04/2019). Participants filled in validated scales measuring happiness, quality of life, and DLQI.
Results
In 102 patients with chronic inflammatory skin diseases, the DLQI was associated only with physical quality of life and negative emotions, and not psychological quality of life or positive affect. The DLQI alone accounted for 26% of variance in general quality of life. Combining DLQI and happiness accounted for a total of 73% of variance, with both variables contributing to the model.
Conclusion
The DLQI alone only partially reflected well-being. Assessing happiness in addition to the widely used DLQI can contribute to a more comprehensive evaluation of well-being.

Identifiants

pubmed: 35866912
doi: 10.1684/ejd.2022.4244
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-226

Auteurs

Barbara Schuster (B)

Technical University of Munich, School of Medicine, Department of Dermatology and Allergy, Biedersteiner Str. 29, 80802 Munich, Germany
Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Pettenkofer School of Public Health, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany

Stefanie Ziehfreund (S)

Technical University of Munich, School of Medicine, Department of Dermatology and Allergy, Biedersteiner Str. 29, 80802 Munich, Germany

Maximilian C Schielein (MC)

Technical University of Munich, School of Medicine, Department of Dermatology and Allergy, Biedersteiner Str. 29, 80802 Munich, Germany
Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Karolinska Universitetssjukhuset, 17176 Stockholm, Sweden

Linda Tizek (L)

Technical University of Munich, School of Medicine, Department of Dermatology and Allergy, Biedersteiner Str. 29, 80802 Munich, Germany

Tilo Biedermann (T)

Technical University of Munich, School of Medicine, Department of Dermatology and Allergy, Biedersteiner Str. 29, 80802 Munich, Germany

Corinna Peifer (C)

Department of Psychology, University of Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany

Alexander Zink (A)

Technical University of Munich, School of Medicine, Department of Dermatology and Allergy, Biedersteiner Str. 29, 80802 Munich, Germany
Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Karolinska Universitetssjukhuset, 17176 Stockholm, Sweden

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH